Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations.

Multiple sclerosis (Houndmills, Basingstoke, England)·2022
Same author

Invasive fungal infections in paediatric patients treated with macromolecular immunomodulators other than tumour necrosis alpha inhibitors.

Mycoses·2017
Same author

New Knowledge About Old Drugs: The Anti-Inflammatory Properties of Cardiac Glycosides.

Planta medica·2017
Same author

Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-α) inhibitors.

Mycoses·2016
Same author

Evidence-Based Phytotherapy in Europe: Where Do We Stand?

Planta medica·2015
Same author

Plant-derived anti-inflammatory compounds: hopes and disappointments regarding the translation of preclinical knowledge into clinical progress.

Mediators of inflammation·2014
Same journal

SARS bereits besiegt?

Pharmazie in unserer Zeit·2020
Same journal

Veranstaltungskalender der DPhG.

Pharmazie in unserer Zeit·2020
Same journal

Fragebogen zur PharmuZ "Arzneimittel gegen Tropenkrankheiten II".

Pharmazie in unserer Zeit·2020
Same journal

Innovationen verbessern Lebensqualität von Patienten mit Hämophilie A.

Pharmazie in unserer Zeit·2020
Same journal

Arzt und Apotheker - vertrauensvolle Partner oder feindliche Brüder?

Pharmazie in unserer Zeit·2020
Same journal

Zytostatika aus dem Meer.

Pharmazie in unserer Zeit·2020
See all related articles

Related Experiment Video

Updated: Jun 5, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

[SiRNA against hepatitis C?]

Ilse Zündorf, Theo Dingermann

    Pharmazie in Unserer Zeit
    |January 4, 2011
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
    04:11

    Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

    Published on: December 15, 2023

    Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
    10:23

    Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

    Published on: April 17, 2017

    Related Experiment Videos

    Last Updated: Jun 5, 2026

    A Protocol for Analyzing Hepatitis C Virus Replication
    13:04

    A Protocol for Analyzing Hepatitis C Virus Replication

    Published on: June 26, 2014

    Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
    04:11

    Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

    Published on: December 15, 2023

    Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
    10:23

    Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

    Published on: April 17, 2017